What is Stevens Johnson Syndrome

Stevens-Johnson Syndrome (SJS) is a rare, life-threatening skin disorder, most often triggered by a severe reaction to medications, that causes painful blistering and the shedding of the top layer of the skin.

Understanding the Condition

Stevens-Johnson Syndrome is categorized as a medical emergency. It primarily affects the skin and the mucous membranes, which are the moist linings of the mouth, eyes, nose, and genital area. In SJS, the body’s immune system mistakenly attacks its own cells, leading to widespread cell death (necrosis) that causes the skin to detach from the underlying layers, resembling a severe burn.

Classification and Prevalence

SJS is part of a spectrum of conditions known as SJS/TEN (Toxic Epidermal Necrolysis). These are classified based on the percentage of body surface area involved: SJS involves less than 10% of the body, while TEN involves more than 30%. SJS/TEN is rare, with an estimated global incidence of 1 to 6 cases per million people annually. Because Stevens-Johnson Syndrome can affect anyone, there is no specific demographic predisposition, though it is more common in individuals with certain genetic markers (such as specific HLA alleles) and those with weakened immune systems.

Pathophysiology and Key Differences

The underlying mechanism of Stevens-Johnson Syndrome involves a T-cell mediated hypersensitivity reaction. When triggered by a drug, these immune cells release proteins that signal skin cells to undergo programmed cell death. What differentiates SJS from other skin conditions, such as Erythema Multiforme (EM), is the heavy involvement of mucous membranes and the direct correlation to systemic medication use rather than viral infections, which are the primary trigger for EM.

Clinical Impact

Patients with Stevens-Johnson Syndrome often experience flu-like symptoms before the appearance of a painful, spreading rash. Immediate withdrawal of the causative medication and supportive care in a specialized burn unit or intensive care unit are essential for survival and recovery.

Disclaimer: This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.

References

• NIH Genetic and Rare Diseases Information Center (GARD)


• Orphanet: The portal for rare diseases and orphan drugs


• OMIM (Online Mendelian Inheritance in Man)


• American Academy of Dermatology (AAD)